Skip to main content
ConductScienceScienceDex

Bradley David Gelfand

NIH Rank #2817
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10480285Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Ophthalmology

NIH Funding · FY2024

Linked Award Amount
$2.9M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#2,817
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Bradley David Gelfand. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Bradley David Gelfand as a PI. Multi-PI records show the full award amount for context.

  • 5R01HL164592-02R01
    Mechanistic basis of sexual dimorphism in antigen-independent IgG1 angiogenesis regulation
    University of Virginia
    $651.1K
    award amount
  • 5R01AG082748-02R01
    Cytosolic SINE retrotransposable element cDNA and mitochondrial DNA in aging retina
    University of Virginia
    $631.8K
    award amount
  • 5R01AG078892-03R01
    Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease
    University of Virginia
    $620.8K
    award amount
  • 5R01EY032512-04R01
    DICER1 deficiency in aberrant chorioretinal neovascularization
    University of Virginia
    $510.4K
    award amount
  • 5R01EY031039-05R01
    Nlrp3 inflammasome activation in early diabetic retinopathy
    University of Virginia
    $472.8K
    award amount

Award organization

Organizations that administered FY2024 awards listing Bradley David Gelfand as a PI.

FY2024 award administered by University of Virginia (VA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Virginia
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2817
  6. 2024
    Entered Top 25% Nationally
    Ranked #2817
  7. 2025
    R01 Grant Holder
  8. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Bradley David Gelfand.

Jayakrishna Ambati
University of Virginia
7
shared awards

Explore further

Find collaborators for Bradley David Gelfand

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →